Israel Active

(Thanks to Atid-EDI) The US FDA has granted orphan designation for Teva’s TREANDA treatment for indolent B-cell non-Hodgkin lymphoma (iNHL). TREANDA is already used for patients with chronic lymphocytic leukemia (CLL).

Israel’s B-Shoe has developed a “smart shoe” that stops wearers from falling if they lose their balance. A microprocessor and patented algorithms detect a stumble triggering the motion device to roll the shoe slightly and gently backwards until the person regains balance.

(Thanks to Atid-EDI) In March I included the NoCamels article about the Dario glucose iPhone monitor from Israel’s LabStyle. In Sept the Dario received the European CE Mark and last week the world launch commenced in the UK, Australia and New Zealand.

A new video showing how much easier life has become for patients with type-1 diabetes who are using the MD-Logic Artificial Pancreas. An international program based at the Schneider Children's Medical Center in Petach Tikvah, Israel.

Israel’s Kadimastem is turning stem cells into beta cells that can produce insulin in the pancreas or nerve cells in the brain. Israel’s Office of the Chief Scientist has just given Kadimastem an NIS 8.5 million grant to continue its research into both technologies.

Israeli biotech Ormed is developing oral medicines to treat conditions that normally require injections. Its flagship product, the ORMD-0801 insulin capsule for Type 1 (juvenile) diabetes has just successfully completed clinical trials. Ormed’s share price rose 115 percent on the news.

Israeli biotech Prolor reported positive pre-clinical trial results of its long-acting anti-obesity drug candidate oxyntomodulin.

Israel’s VBL Therapeutics has developed VB-201 – the first of a new class of oral anti-inflammatories called Lecinoxoids. VB-201 has the potential to treat immune-inflammatory diseases such as Psoriasis, Inflammatory Bowel Disease, Multiple Sclerosis, Rheumatoid Arthritis and more. The US FDA has also granted fast-track designation for VB-111, which treats GBM - an aggressive form of brain cancer.

Staff at Hadassah Medical Center in Jerusalem worked 16-hour shifts to meet the needs of 80 women who gave birth during the recent snowstorm. Rescue teams transported expectant mothers to the hospital and some MDA ambulances conveyed two pregnant women.

Israel Brain Technologies has signed an agreement with four US organizations to create a partnership in neuroscience research, and in particular Alzheimer's disease.